We haven’t reached mid-year 2019, and the United States has already experienced several severe weather events, including a polar vortex and many hail storms in the Midwest, massive flooding in the Northern Plains, and heavy El Niño rains in California.
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the Medicare Set-Aside services Genex provides.
CMS has indicated that beginning January 5, 2019, they will convert to using the CDC’s “Table 1: Life Table for the total population: United States, 2015“ for the Workers’ Compensation Medicare Set Aside life expectancy calculations.
The American Medical Association (AMA) 2019 Current Procedural Terminology (CPT) code set is here! There are a total of 335 code changes in the 2019 code set. How will these changes impact the casualty industry? After an intensive review of the new CPT code book, the most notable changes are technology-based.
Average Length of Rental (LOR) for Q3 2018 landed at 12 days in the United States which is even compared to Q3 2017. This is the second consecutive year that Q3 LOR has been flat versus the prior year. Once again, there was very little consistency between regions and states, suggesting that the quarterly result for the U.S. is not reflective of a genuine national trend.
When mobile phones were first made available to consumers more than thirty years ago, it was difficult to imagine that they would become the hubs of Internet access, information and activity—even health tracking—that we know them to be today. Similarly, it may be difficult to imagine that smart phones, and indeed the world around us, will soon be embedded with artificial intelligence. But that appears to be the direction things are headed.
Managing the pharmacy portion of a workers’ compensation or auto accident-related claim is vital to ensure the best outcomes. An important area to monitor during claims is the usage of brand name medications when generic equivalents are available.